aminolevulinic acid has been researched along with Invasiveness, Neoplasm in 68 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the utility and safety of photodynamic diagnosis (PDD) after oral administration of 5-aminolevulinic acid (5-ALA) (ALA-PDD) of non-muscle-invasive bladder cancer (NMIBC) using fluorescent-light (FL)-cystoscopy." | 9.22 | The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA). ( Azuma, H; Fujimoto, K; Hirao, Y; Inoue, K; Ito, YM; Matsubara, A; Matsuyama, H; Mimata, H; Nagase, Y; Oyama, M; Ozono, S; Shiina, H; Shuin, T; Sugimura, Y; Ueno, M; Watanabe, H, 2016) |
| "Patient selection for transurethral resection of the bladder tumor using photodynamic diagnosis (PDD-TURBT) with oral 5-aminolevulinic acid (5-ALA) hydrochloride for non-muscle-invasive bladder cancer (NMIBC) is still unclear as to the best balance of risks (adverse events including hypotension) and benefits (reduction of intravesical recurrence)." | 8.31 | Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer. ( Hirata, H; Hiroyoshi, T; Isoyama, N; Ito, H; Kobayashi, K; Matsumoto, H; Matsuyama, H; Misumi, T; Nakamura, K; Oka, S; Shiraishi, K, 2023) |
| "Photodynamic diagnosis (PDD) with administration of oral aminolevulinic acid (ALA) prior to transurethral resection of bladder tumor (TURBT) can now be used for non-muscle invasive bladder cancer (NMIBC) in clinical settings in Japan." | 8.12 | Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT. ( Fukuhara, H; Furihata, M; Inoue, K; Karashima, T; Kurabayashi, A; Lai, HW; Yamamoto, S, 2022) |
| "5-Aminolevulinic acid-induced PpIX fluorescence was assessed in GL261-Luc2 cells in vitro and in vivo after implantation in mouse brains, at an invading glioma growth stage, simulating residual tumor." | 7.88 | Scanning Fiber Endoscope Improves Detection of 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence at the Boundary of Infiltrative Glioma. ( Belykh, E; Byvaltsev, VA; Hu, D; Martirosyan, NL; Miller, EJ; Nakaji, P; Nelson, LY; Preul, MC; Scheck, AC; Seibel, EJ; Woolf, EC, 2018) |
| " SFE may allow accurate imaging of 5-aminolevulinic acid labeling of gliomas and other tumor types when current detection techniques have failed to provide reliable visualization." | 7.88 | Scanning Fiber Endoscope Improves Detection of 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence at the Boundary of Infiltrative Glioma. ( Belykh, E; Byvaltsev, VA; Hu, D; Martirosyan, NL; Miller, EJ; Nakaji, P; Nelson, LY; Preul, MC; Scheck, AC; Seibel, EJ; Woolf, EC, 2018) |
| "Fluorescence-guided surgery with protoporphyrin IX (PpIX) as a photodiagnostic marker is gaining acceptance for resection of malignant gliomas." | 7.88 | Scanning Fiber Endoscope Improves Detection of 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence at the Boundary of Infiltrative Glioma. ( Belykh, E; Byvaltsev, VA; Hu, D; Martirosyan, NL; Miller, EJ; Nakaji, P; Nelson, LY; Preul, MC; Scheck, AC; Seibel, EJ; Woolf, EC, 2018) |
| "This study was undertaken to evaluate the clinical value of photodynamic diagnosis (PDD) with intravesical and oral instillation of 5-aminolevulinic acid (ALA) (ALA-PDD), and transurethral resection of bladder tumor (TURBT) guided by ALA-PDD (PDD-TURBT) for nonmuscle invasive bladder cancer." | 7.78 | Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer. ( Fukuhara, H; Furihata, M; Iiyama, T; Inoue, K; Kamada, M; Kurabayashi, A; Miyamura, M; Shimamoto, T; Shuin, T; Tanimura, M; Watanabe, H, 2012) |
| "ALA-PDD was shown to be safe and effective." | 6.82 | The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA). ( Azuma, H; Fujimoto, K; Hirao, Y; Inoue, K; Ito, YM; Matsubara, A; Matsuyama, H; Mimata, H; Nagase, Y; Oyama, M; Ozono, S; Shiina, H; Shuin, T; Sugimura, Y; Ueno, M; Watanabe, H, 2016) |
| "Regarding safety, the adverse drug reactions were observed as grade 1 pruritus in 1 patient (0." | 6.82 | The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA). ( Azuma, H; Fujimoto, K; Hirao, Y; Inoue, K; Ito, YM; Matsubara, A; Matsuyama, H; Mimata, H; Nagase, Y; Oyama, M; Ozono, S; Shiina, H; Shuin, T; Sugimura, Y; Ueno, M; Watanabe, H, 2016) |
| "The frequency of recurrence was lower and the time to recurrence was longer in the PDD-TURBT group than in the WL-TURBT group." | 5.72 | Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT. ( Fukuhara, H; Furihata, M; Inoue, K; Karashima, T; Kurabayashi, A; Lai, HW; Yamamoto, S, 2022) |
| "This study compared tumor recurrence among NMIBC patients who underwent TURBT under either white light cystoscopy (WL) or PDD." | 5.72 | Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT. ( Fukuhara, H; Furihata, M; Inoue, K; Karashima, T; Kurabayashi, A; Lai, HW; Yamamoto, S, 2022) |
| "The frequency of recurrence in NMIBC patients (cumulative number of recurrences/cumulative number of follow-up days, number of recurrences/10,000 days), including progression to muscle-invasive bladder cancer (MIBC), was 12." | 5.72 | Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT. ( Fukuhara, H; Furihata, M; Inoue, K; Karashima, T; Kurabayashi, A; Lai, HW; Yamamoto, S, 2022) |
| "Chordomas are very rare tumors of the skull base and the sacrum." | 5.46 | 5-Aminolevulinic acid-based photodynamic therapy of chordoma: In vitro experiments on a human tumor cell line. ( Cornelius, JF; Ebbert, L; Eismann, L; Kamp, MA; Petridis, AK; Senger, B; Sorg, RV; Steiger, HJ, 2017) |
| "To assess the efficacy of two treatment options for non-muscle-invasive bladder cancer (NMIBC): (1) transurethral resection (TUR) guided by fluorescence cystoscopy (FC) with the use of 5-aminolevulinic acid (5-ALA) and (2) single early instillation of doxorubicin in a single-center open-label prospective randomized study with a 2 × 2 factorial design." | 5.24 | Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer. ( Krasny, SA; Minich, AA; Mokhort, AA; Polyakov, SL; Rolevich, AI; Sukonko, OG; Vasilevich, VY; Zhegalik, AG, 2017) |
| "To examine the utility and safety of photodynamic diagnosis (PDD) after oral administration of 5-aminolevulinic acid (5-ALA) (ALA-PDD) of non-muscle-invasive bladder cancer (NMIBC) using fluorescent-light (FL)-cystoscopy." | 5.22 | The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA). ( Azuma, H; Fujimoto, K; Hirao, Y; Inoue, K; Ito, YM; Matsubara, A; Matsuyama, H; Mimata, H; Nagase, Y; Oyama, M; Ozono, S; Shiina, H; Shuin, T; Sugimura, Y; Ueno, M; Watanabe, H, 2016) |
| "Controversy exists regarding the therapeutic benefit and cost effectiveness of photodynamic diagnosis (PDD) with 5-aminolevulinic acid (5-ALA) or hexyl aminolevulinate (HAL) in addition to white-light cystoscopy (WLC) in the management of non-muscle-invasive bladder cancer (NMIBC)." | 4.89 | Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. ( Babjuk, M; Catto, JW; Jichlinski, P; Rink, M; Shariat, SF; Stenzl, A; Stepp, H; Witjes, JA; Zaak, D, 2013) |
| "The clinical benefit of photodynamic diagnosis (PDD) with 5-aminolevulinic acid or hexaminolevulinate in addition to white-light cystoscopy (WLC) in bladder cancer has been discussed controversially." | 4.86 | Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. ( Jacqmin, D; Jichlinski, P; Jocham, D; Kausch, I; Montorsi, F; Sommerauer, M; Stenzl, A; Vonthein, R; Ziegler, A, 2010) |
| "Patient selection for transurethral resection of the bladder tumor using photodynamic diagnosis (PDD-TURBT) with oral 5-aminolevulinic acid (5-ALA) hydrochloride for non-muscle-invasive bladder cancer (NMIBC) is still unclear as to the best balance of risks (adverse events including hypotension) and benefits (reduction of intravesical recurrence)." | 4.31 | Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer. ( Hirata, H; Hiroyoshi, T; Isoyama, N; Ito, H; Kobayashi, K; Matsumoto, H; Matsuyama, H; Misumi, T; Nakamura, K; Oka, S; Shiraishi, K, 2023) |
| "Photodynamic diagnosis (PDD) with administration of oral aminolevulinic acid (ALA) prior to transurethral resection of bladder tumor (TURBT) can now be used for non-muscle invasive bladder cancer (NMIBC) in clinical settings in Japan." | 4.12 | Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT. ( Fukuhara, H; Furihata, M; Inoue, K; Karashima, T; Kurabayashi, A; Lai, HW; Yamamoto, S, 2022) |
| "Photodynamic diagnosis (PDD) using 5-aminolevulinic acid (5-ALA) is expected to be useful in preventing oversight of non-muscle-invasive bladder cancer (NMIBC) and in reducing the intravesical recurrence rate after transurethral resection of bladder tumor (TURBT)." | 4.02 | [Initial Experience of Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumor (PDD-TURBT)]. ( Inoue, T; Kanda, H; Kato, M; Masui, S; Nishikawa, K; Sasaki, T; Sugimura, Y; Sugino, Y; Yoshio, Y, 2021) |
| "Photodynamic therapy (PDT) has been reported as a treatment for cutaneous squamous cell carcinoma in situ (SCCis), but only limited data are available on the effectiveness of PDT with aminolevulinic acid (ALA-PDT)." | 3.96 | Photodynamic therapy for cutaneous squamous cell carcinoma in situ: Impact of anatomic location, tumor diameter, and incubation time on effectiveness. ( Christensen, SR; Kibbi, N; Leffell, DJ; Zhang, Y, 2020) |
| "5-Aminolevulinic acid-induced PpIX fluorescence was assessed in GL261-Luc2 cells in vitro and in vivo after implantation in mouse brains, at an invading glioma growth stage, simulating residual tumor." | 3.88 | Scanning Fiber Endoscope Improves Detection of 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence at the Boundary of Infiltrative Glioma. ( Belykh, E; Byvaltsev, VA; Hu, D; Martirosyan, NL; Miller, EJ; Nakaji, P; Nelson, LY; Preul, MC; Scheck, AC; Seibel, EJ; Woolf, EC, 2018) |
| " SFE may allow accurate imaging of 5-aminolevulinic acid labeling of gliomas and other tumor types when current detection techniques have failed to provide reliable visualization." | 3.88 | Scanning Fiber Endoscope Improves Detection of 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence at the Boundary of Infiltrative Glioma. ( Belykh, E; Byvaltsev, VA; Hu, D; Martirosyan, NL; Miller, EJ; Nakaji, P; Nelson, LY; Preul, MC; Scheck, AC; Seibel, EJ; Woolf, EC, 2018) |
| "Fluorescence-guided surgery with protoporphyrin IX (PpIX) as a photodiagnostic marker is gaining acceptance for resection of malignant gliomas." | 3.88 | Scanning Fiber Endoscope Improves Detection of 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence at the Boundary of Infiltrative Glioma. ( Belykh, E; Byvaltsev, VA; Hu, D; Martirosyan, NL; Miller, EJ; Nakaji, P; Nelson, LY; Preul, MC; Scheck, AC; Seibel, EJ; Woolf, EC, 2018) |
| "This study was undertaken to evaluate the clinical value of photodynamic diagnosis (PDD) with intravesical and oral instillation of 5-aminolevulinic acid (ALA) (ALA-PDD), and transurethral resection of bladder tumor (TURBT) guided by ALA-PDD (PDD-TURBT) for nonmuscle invasive bladder cancer." | 3.78 | Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer. ( Fukuhara, H; Furihata, M; Iiyama, T; Inoue, K; Kamada, M; Kurabayashi, A; Miyamura, M; Shimamoto, T; Shuin, T; Tanimura, M; Watanabe, H, 2012) |
| "ALA-PDD was shown to be safe and effective." | 2.82 | The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA). ( Azuma, H; Fujimoto, K; Hirao, Y; Inoue, K; Ito, YM; Matsubara, A; Matsuyama, H; Mimata, H; Nagase, Y; Oyama, M; Ozono, S; Shiina, H; Shuin, T; Sugimura, Y; Ueno, M; Watanabe, H, 2016) |
| "Regarding safety, the adverse drug reactions were observed as grade 1 pruritus in 1 patient (0." | 2.82 | The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA). ( Azuma, H; Fujimoto, K; Hirao, Y; Inoue, K; Ito, YM; Matsubara, A; Matsuyama, H; Mimata, H; Nagase, Y; Oyama, M; Ozono, S; Shiina, H; Shuin, T; Sugimura, Y; Ueno, M; Watanabe, H, 2016) |
| "Non-muscle-invasive bladder cancer (NMIBC) is associated with a high recurrence risk, partly because of the persistence of lesions following transurethral resection of bladder tumour (TURBT) due to the presence of multiple lesions and the difficulty in identifying the exact extent and location of tumours using standard white-light cystoscopy (WLC)." | 2.50 | Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations. ( Babjuk, M; Gontero, P; Jacqmin, D; Karl, A; Kruck, S; Mariappan, P; Palou Redorta, J; Stenzl, A; van Velthoven, R; Witjes, JA; Zaak, D, 2014) |
| "Residual tumour was significantly less often found after PDD (odds ratio: 0." | 2.46 | Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. ( Jacqmin, D; Jichlinski, P; Jocham, D; Kausch, I; Montorsi, F; Sommerauer, M; Stenzl, A; Vonthein, R; Ziegler, A, 2010) |
| "Non-muscle invasive bladder cancer is the most expensive cancer to manage on a per patient basis due to the high recurrence rate, low mortality and the need for long term, often lifelong surveillance." | 2.44 | The economic benefit of photodynamic diagnosis in non-muscle invasive bladder cancer. ( Bunce, CJ; Dindyal, S; Nitkunan, T, 2008) |
| "This study compared tumor recurrence among NMIBC patients who underwent TURBT under either white light cystoscopy (WL) or PDD." | 1.72 | Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT. ( Fukuhara, H; Furihata, M; Inoue, K; Karashima, T; Kurabayashi, A; Lai, HW; Yamamoto, S, 2022) |
| "The frequency of recurrence was lower and the time to recurrence was longer in the PDD-TURBT group than in the WL-TURBT group." | 1.72 | Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT. ( Fukuhara, H; Furihata, M; Inoue, K; Karashima, T; Kurabayashi, A; Lai, HW; Yamamoto, S, 2022) |
| "The frequency of recurrence in NMIBC patients (cumulative number of recurrences/cumulative number of follow-up days, number of recurrences/10,000 days), including progression to muscle-invasive bladder cancer (MIBC), was 12." | 1.72 | Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT. ( Fukuhara, H; Furihata, M; Inoue, K; Karashima, T; Kurabayashi, A; Lai, HW; Yamamoto, S, 2022) |
| "Chordomas are very rare tumors of the skull base and the sacrum." | 1.46 | 5-Aminolevulinic acid-based photodynamic therapy of chordoma: In vitro experiments on a human tumor cell line. ( Cornelius, JF; Ebbert, L; Eismann, L; Kamp, MA; Petridis, AK; Senger, B; Sorg, RV; Steiger, HJ, 2017) |
| "Mean residual tumor volume (range) after iMRI-assisted surgery [0." | 1.40 | Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery. ( Bisdas, S; Ebner, FH; Ernemann, U; Honegger, J; Naegele, T; Roder, C; Tatagiba, M, 2014) |
| "Five-aminolevulinic acid (ALA) has received much attention recently as a new-generation photosensitive substance for photodynamic diagnosis (PDD)." | 1.40 | Photodynamic diagnosis using 5-aminolevulinic acid during gastrectomy for gastric cancer. ( Fukuhara, H; Hanazaki, K; Inoue, K; Kitagawa, H; Kobayashi, M; Maeda, H; Namikawa, T; Shiga, M; Shuin, T; Uemura, S, 2014) |
| "Analysis of residual tumor volumes, total resections and neurological outcomes demonstrate that iMRI may be significantly superior to 5-ALA and white-light surgery for glioblastomas at comparable peri- and postoperative morbidities." | 1.40 | Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery. ( Bisdas, S; Ebner, FH; Ernemann, U; Honegger, J; Naegele, T; Roder, C; Tatagiba, M, 2014) |
| "5-aminolevulinic acid (5-ALA) has gained importance as an intraoperative photodynamic diagnostic agent for the extirpation of malignant gliomas." | 1.36 | Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas. ( Coluccia, D; Cordovi, S; Fandino, J; Fujioka, M; Landolt, H; Muroi, C, 2010) |
| "It has a tendency to metastasise to regional or distant sites after incomplete treatment." | 1.34 | Photodynamic therapy suppresses the migration and invasion of head and neck cancer cells in vitro. ( Chen, CT; Lou, PJ; Wang, CP; Yang, TH, 2007) |
| "Head and neck cancer is highly invasive." | 1.34 | Photodynamic therapy suppresses the migration and invasion of head and neck cancer cells in vitro. ( Chen, CT; Lou, PJ; Wang, CP; Yang, TH, 2007) |
| "High-grade gliomas are characterized by rapid proliferation, angiogenesis, and invasive growth." | 1.33 | Effects of ALA-mediated photodynamic therapy on the invasiveness of human glioma cells. ( Hirschberg, H; Krasieva, T; Madsen, SJ; Sun, CH, 2006) |
| "The prognosis of superficial bladder cancer in terms of local recurrence and transformation into invasive cancer is related to the multiplicity of tumor sites and the concomitant presence of "flat" tumours, such as dysplasia and carcinoma in situ." | 1.30 | [The clinical value of fluorescence cystoscopy in the detection of superficial transitional epithelial cell carcinoma of the bladder]. ( Forrer, M; Graber, P; Guillou, L; Jichlinski, P; Leisinger, HJ; Mizeret, J; Schmidlin, F; Van den Bergh, H; Wagniéres, G, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (2.94) | 18.2507 |
| 2000's | 15 (22.06) | 29.6817 |
| 2010's | 44 (64.71) | 24.3611 |
| 2020's | 7 (10.29) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuhara, H | 4 |
| Inoue, K | 5 |
| Yamamoto, S | 1 |
| Lai, HW | 1 |
| Karashima, T | 1 |
| Kurabayashi, A | 2 |
| Furihata, M | 2 |
| Kobayashi, K | 1 |
| Matsuyama, H | 2 |
| Oka, S | 1 |
| Nakamura, K | 1 |
| Misumi, T | 1 |
| Hiroyoshi, T | 1 |
| Ito, H | 1 |
| Isoyama, N | 1 |
| Hirata, H | 1 |
| Matsumoto, H | 1 |
| Shiraishi, K | 1 |
| Kibbi, N | 1 |
| Zhang, Y | 1 |
| Leffell, DJ | 1 |
| Christensen, SR | 1 |
| Williams, SB | 1 |
| Gavaghan, MB | 1 |
| Fernandez, A | 1 |
| Daneshmand, S | 3 |
| Kamat, AM | 3 |
| Sugino, Y | 1 |
| Nishikawa, K | 1 |
| Kato, M | 2 |
| Sasaki, T | 1 |
| Masui, S | 1 |
| Yoshio, Y | 1 |
| Kanda, H | 1 |
| Sugimura, Y | 2 |
| Inoue, T | 1 |
| Jacqmin, D | 5 |
| Jichlinski, P | 6 |
| Molinier, L | 2 |
| de la Taille, A | 1 |
| Irani, J | 1 |
| Malavaud, B | 2 |
| Gallagher, KM | 1 |
| Gray, K | 1 |
| Anderson, CH | 1 |
| Lee, H | 1 |
| Stewart, S | 1 |
| Donat, R | 1 |
| Mariappan, P | 2 |
| Yagi, R | 1 |
| Kawabata, S | 1 |
| Ikeda, N | 1 |
| Nonoguchi, N | 1 |
| Furuse, M | 1 |
| Katayama, Y | 2 |
| Kajimoto, Y | 2 |
| Kuroiwa, T | 2 |
| Belykh, E | 1 |
| Miller, EJ | 1 |
| Hu, D | 1 |
| Martirosyan, NL | 1 |
| Woolf, EC | 1 |
| Scheck, AC | 1 |
| Byvaltsev, VA | 1 |
| Nakaji, P | 1 |
| Nelson, LY | 1 |
| Seibel, EJ | 1 |
| Preul, MC | 1 |
| Rioli, DI | 1 |
| Samimi, M | 1 |
| Beneton, N | 1 |
| Hainaut, E | 1 |
| Martin, L | 1 |
| Misery, L | 1 |
| Quereux, G | 1 |
| Safar, R | 1 |
| Alkhars, A | 1 |
| Tallegas, M | 1 |
| Korsaga-Some, N | 1 |
| Machet, L | 1 |
| Lotan, Y | 1 |
| Bivalacqua, TJ | 1 |
| Downs, T | 1 |
| Huang, W | 1 |
| Jones, J | 1 |
| Konety, B | 1 |
| Malmström, PU | 2 |
| McKiernan, J | 1 |
| O'Donnell, M | 1 |
| Patel, S | 1 |
| Pohar, K | 1 |
| Resnick, M | 1 |
| Sankin, A | 1 |
| Smith, A | 1 |
| Steinberg, G | 1 |
| Trabulsi, E | 1 |
| Woods, M | 1 |
| Renninger, M | 1 |
| Fahmy, O | 1 |
| Schubert, T | 1 |
| Schmid, MA | 1 |
| Hassan, F | 1 |
| Stenzl, A | 7 |
| Gakis, G | 1 |
| Konecki, T | 1 |
| Kutwin, P | 1 |
| Łowicki, R | 1 |
| Juszczak, AB | 1 |
| Jabłonowski, Z | 1 |
| Cage, TA | 1 |
| Pekmezci, M | 1 |
| Prados, M | 1 |
| Berger, MS | 1 |
| Ferré, A | 1 |
| Cordonnier, C | 1 |
| Demailly, M | 1 |
| Hakami, F | 1 |
| Sevestre, H | 1 |
| Saint, F | 1 |
| Roozeboom, MH | 1 |
| Aardoom, MA | 1 |
| Nelemans, PJ | 1 |
| Thissen, MR | 1 |
| Kelleners-Smeets, NW | 1 |
| Kuijpers, DI | 1 |
| Mosterd, K | 2 |
| Burger, M | 4 |
| Grossman, HB | 3 |
| Droller, M | 1 |
| Schmidbauer, J | 1 |
| Hermann, G | 1 |
| Drăgoescu, O | 2 |
| Ray, E | 1 |
| Fradet, Y | 2 |
| Karl, A | 3 |
| Burgués, JP | 1 |
| Witjes, JA | 6 |
| Jocham, D | 4 |
| Lippert, J | 1 |
| Smucler, R | 1 |
| Vlk, M | 1 |
| Rink, M | 1 |
| Babjuk, M | 3 |
| Catto, JW | 1 |
| Shariat, SF | 1 |
| Stepp, H | 2 |
| Zaak, D | 4 |
| Namikawa, T | 1 |
| Uemura, S | 1 |
| Shiga, M | 1 |
| Maeda, H | 1 |
| Kitagawa, H | 1 |
| Kobayashi, M | 1 |
| Shuin, T | 3 |
| Hanazaki, K | 1 |
| Gkritsios, P | 1 |
| Hatzimouratidis, K | 1 |
| Kazantzidis, S | 1 |
| Dimitriadis, G | 1 |
| Ioannidis, E | 1 |
| Katsikas, V | 1 |
| Roder, C | 1 |
| Bisdas, S | 1 |
| Ebner, FH | 1 |
| Honegger, J | 1 |
| Naegele, T | 1 |
| Ernemann, U | 1 |
| Tatagiba, M | 1 |
| Gilaberte, Y | 1 |
| Milla, L | 1 |
| Salazar, N | 1 |
| Vera-Alvarez, J | 1 |
| Kourani, O | 1 |
| Damian, A | 1 |
| Rivarola, V | 1 |
| Roca, MJ | 1 |
| Espada, J | 1 |
| González, S | 1 |
| Juarranz, A | 1 |
| Fargnoli, MC | 1 |
| Kostaki, D | 1 |
| Piccioni, A | 1 |
| Di Stefani, A | 1 |
| Peris, K | 1 |
| Gontero, P | 1 |
| Kruck, S | 1 |
| Palou Redorta, J | 1 |
| van Velthoven, R | 1 |
| Schuckman, AK | 1 |
| Bochner, BH | 1 |
| Cookson, MS | 1 |
| Downs, TM | 1 |
| Gomella, LG | 1 |
| Konety, BR | 1 |
| Lee, CT | 1 |
| Pohar, KS | 1 |
| Pruthi, RS | 1 |
| Resnick, MJ | 1 |
| Smith, ND | 1 |
| Schoenberg, MP | 1 |
| Steinberg, GD | 1 |
| Rouprêt, M | 1 |
| Leleu, H | 1 |
| Blachier, M | 1 |
| Marteau, F | 1 |
| Li, PT | 1 |
| Tsai, YJ | 1 |
| Lee, MJ | 1 |
| Chen, CT | 3 |
| Fujimoto, K | 1 |
| Hirao, Y | 1 |
| Watanabe, H | 2 |
| Ozono, S | 1 |
| Oyama, M | 1 |
| Ueno, M | 1 |
| Shiina, H | 1 |
| Mimata, H | 1 |
| Azuma, H | 1 |
| Nagase, Y | 1 |
| Matsubara, A | 1 |
| Ito, YM | 1 |
| Kessels, J | 1 |
| Hendriks, J | 1 |
| Nelemans, P | 1 |
| Kelleners-Smeets, N | 1 |
| Bach, T | 1 |
| Bastian, PJ | 1 |
| Blana, A | 1 |
| Kaminsky, A | 1 |
| Keller, S | 1 |
| Knoll, T | 1 |
| Lang, C | 1 |
| Promnitz, S | 1 |
| Ubrig, B | 1 |
| Keller, T | 1 |
| Qvick, B | 1 |
| Rolevich, AI | 1 |
| Zhegalik, AG | 1 |
| Mokhort, AA | 1 |
| Minich, AA | 1 |
| Vasilevich, VY | 1 |
| Polyakov, SL | 1 |
| Krasny, SA | 1 |
| Sukonko, OG | 1 |
| Filonenko, EV | 1 |
| Kaprin, AD | 1 |
| Alekseev, BY | 1 |
| Apolikhin, OI | 1 |
| Slovokhodov, EK | 1 |
| Ivanova-Radkevich, VI | 1 |
| Urlova, AN | 1 |
| Fahey, JM | 1 |
| Girotti, AW | 1 |
| Choi, SH | 1 |
| Kim, KH | 1 |
| Song, KH | 1 |
| Madsen, SJ | 2 |
| Mathews, MS | 1 |
| Angell-Petersen, E | 1 |
| Sun, CH | 2 |
| Vo, V | 1 |
| Sanchez, R | 1 |
| Hirschberg, H | 2 |
| Tsai, T | 1 |
| Ji, HT | 1 |
| Chiang, PC | 1 |
| Chou, RH | 1 |
| Chang, WS | 1 |
| Dindyal, S | 1 |
| Nitkunan, T | 1 |
| Bunce, CJ | 1 |
| Draga, RO | 1 |
| Bosch, JL | 1 |
| Grimbergen, MC | 1 |
| Kausch, I | 2 |
| Sommerauer, M | 2 |
| Montorsi, F | 3 |
| Ziegler, A | 2 |
| Vonthein, R | 2 |
| Bunce, C | 1 |
| Ayres, BE | 1 |
| Griffiths, TR | 1 |
| Mostafid, H | 1 |
| Kelly, J | 1 |
| Persad, R | 1 |
| Kockelbergh, R | 1 |
| Redorta, JP | 1 |
| Sofras, F | 1 |
| Riedl, C | 1 |
| Conti, G | 1 |
| Arentsen, HC | 1 |
| Mostafid, AH | 1 |
| Park, JH | 1 |
| Moon, YH | 1 |
| Kim, DJ | 1 |
| Kim, SA | 1 |
| Lee, JB | 1 |
| Ahn, SG | 1 |
| Yoon, JH | 1 |
| Coluccia, D | 1 |
| Fandino, J | 1 |
| Fujioka, M | 1 |
| Cordovi, S | 1 |
| Muroi, C | 1 |
| Landolt, H | 1 |
| Li, Q | 1 |
| Gao, T | 1 |
| Long, HA | 1 |
| Ujiie, H | 1 |
| Hefti, M | 1 |
| Tomescu, P | 1 |
| Pănuş, A | 1 |
| Enache, M | 1 |
| Maria, C | 1 |
| Stoica, L | 1 |
| Pleşea, IE | 1 |
| Shimamoto, T | 1 |
| Kamada, M | 1 |
| Iiyama, T | 1 |
| Miyamura, M | 1 |
| Tanimura, M | 1 |
| Kishi, K | 1 |
| Fujiwara, Y | 1 |
| Yano, M | 1 |
| Inoue, M | 1 |
| Miyashiro, I | 1 |
| Motoori, M | 1 |
| Shingai, T | 1 |
| Gotoh, K | 1 |
| Takahashi, H | 1 |
| Noura, S | 1 |
| Yamada, T | 1 |
| Ohue, M | 1 |
| Ohigashi, H | 1 |
| Ishikawa, O | 1 |
| Mynderse, LA | 1 |
| Kriegmair, M | 1 |
| Soloway, MS | 1 |
| Akoel, KM | 1 |
| Welfel, J | 1 |
| Gottwald, L | 1 |
| Suzin, J | 1 |
| Gamarra, F | 1 |
| Lingk, P | 1 |
| Marmarova, A | 1 |
| Edelmann, M | 1 |
| Hautmann, H | 1 |
| Baumgartner, R | 1 |
| Huber, RM | 1 |
| Schleier, P | 1 |
| Hyckel, P | 1 |
| Berndt, A | 1 |
| Bode, HP | 1 |
| Albrecht, V | 1 |
| Hindermann, W | 1 |
| Kosmehl, H | 1 |
| Zenk, W | 1 |
| Schumann, D | 1 |
| Arens, C | 1 |
| Utsuki, S | 1 |
| Oka, H | 1 |
| Sato, S | 1 |
| Suzuki, S | 1 |
| Shimizu, S | 1 |
| Tanaka, S | 1 |
| Fujii, K | 1 |
| Au, CM | 1 |
| Luk, SK | 1 |
| Jackson, CJ | 1 |
| Ng, HK | 1 |
| Yow, CM | 1 |
| To, SS | 1 |
| Yang, TH | 1 |
| Wang, CP | 1 |
| Lou, PJ | 1 |
| Krasieva, T | 1 |
| Ishihara, R | 1 |
| Watanabe, T | 1 |
| Yoshino, A | 1 |
| Fukushima, T | 1 |
| Sakatani, K | 1 |
| Miyatake, S | 1 |
| Ichioka, T | 1 |
| Miyashita, M | 1 |
| Tanaka, H | 1 |
| Tsuji, M | 1 |
| Denzinger, S | 1 |
| Hartmann, A | 1 |
| Hofstaedter, F | 1 |
| Knuechel, R | 1 |
| Wild, PJ | 1 |
| Stief, C | 1 |
| Wieland, WF | 1 |
| Stoehr, R | 1 |
| Lui, H | 1 |
| Salasche, S | 1 |
| Kollias, N | 1 |
| Wimberly, J | 1 |
| Flotte, T | 1 |
| McLean, D | 1 |
| Anderson, RR | 1 |
| Wagniéres, G | 1 |
| Forrer, M | 1 |
| Mizeret, J | 1 |
| Guillou, L | 1 |
| Schmidlin, F | 1 |
| Graber, P | 1 |
| Van den Bergh, H | 1 |
| Leisinger, HJ | 1 |
| Kitada, M | 1 |
| Ohsaki, Y | 1 |
| Yasuda, S | 1 |
| Abe, M | 1 |
| Takahashi, N | 1 |
| Okazaki, S | 1 |
| Ishibashi, K | 1 |
| Hayashi, S | 1 |
| Cornelius, JF | 1 |
| Eismann, L | 1 |
| Ebbert, L | 1 |
| Senger, B | 1 |
| Petridis, AK | 1 |
| Kamp, MA | 1 |
| Sorg, RV | 1 |
| Steiger, HJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Safety Analysis and Oncological Outcomes in Endoscopic Bladder Tumor Resection With Laser Holmium Compared With Transurethral Resection: a Prospective and Randomized Study[NCT05833997] | 100 participants (Anticipated) | Interventional | 2020-12-10 | Recruiting | |||
| A Randomised Trial Comparing Methyl Aminolaevulinate Photodynamic Therapy With and Without Ablative Fractional Laser Treatment in Patients With Microinvasive Squamous Cell Carcinoma: Results From a 24-month Follow-up[NCT02666534] | Phase 1 | 45 participants (Actual) | Interventional | 2012-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for aminolevulinic acid and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018.
Topics: Aminolevulinic Acid; Consensus Development Conferences as Topic; Cystectomy; Cystoscopes; Cystoscopy | 2019 |
Hexaminolevulinate in the Management of Nonmuscle Invasive Bladder Cancer: A Meta-Analysis.
Topics: Aminolevulinic Acid; Carcinoma in Situ; Cystoscopy; Humans; Neoplasm Invasiveness; Photosensitizing | 2019 |
Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.
Topics: Aminolevulinic Acid; Carcinoma in Situ; Cystoscopy; Humans; Kaplan-Meier Estimate; Neoplasm Invasive | 2013 |
Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.
Topics: Aminolevulinic Acid; Cost-Benefit Analysis; Cystectomy; Cystoscopy; Disease-Free Survival; Health Ca | 2013 |
Photodynamic therapy for the treatment of microinvasive squamous cell carcinoma of the lower lip: a case report.
Topics: Aged; Aminolevulinic Acid; Carcinoma, Squamous Cell; Cheilitis; Dermoscopy; Humans; Lip Neoplasms; M | 2015 |
Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.
Topics: Aminolevulinic Acid; Cost-Benefit Analysis; Cystectomy; Cystoscopy; Disease Progression; Disease-Fre | 2014 |
Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.
Topics: Aminolevulinic Acid; Carcinoma, Transitional Cell; Consensus; Cystoscopy; Humans; Neoplasm Invasiven | 2014 |
The economic benefit of photodynamic diagnosis in non-muscle invasive bladder cancer.
Topics: Aminolevulinic Acid; Carcinoma, Transitional Cell; Fluorescence; Humans; Neoplasm Invasiveness; Phot | 2008 |
Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies.
Topics: Aminolevulinic Acid; Cystectomy; Cystoscopy; Disease-Free Survival; Evidence-Based Medicine; Humans; | 2010 |
The role of hexylaminolaevulinate in the diagnosis and follow-up of non-muscle-invasive bladder cancer.
Topics: Aminolevulinic Acid; Cystoscopy; Humans; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Photosen | 2010 |
Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations.
Topics: Aminolevulinic Acid; Cystectomy; Cystoscopy; Disease-Free Survival; Evidence-Based Medicine; Humans; | 2010 |
[Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: results of a metaanalysis].
Topics: Aminolevulinic Acid; Cystoscopy; Disease-Free Survival; Fluorescence; Humans; Neoplasm Invasiveness; | 2010 |
8 trials available for aminolevulinic acid and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Combined Modality Therap | 2013 |
Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial.
Topics: Aged; Aminolevulinic Acid; Color; Contrast Media; Cystoscopy; Disease-Free Survival; False Positive | 2014 |
The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA).
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Contrast Media; Cystoscop | 2016 |
Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer.
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Antibiotics, Anti | 2017 |
5-Aminolevulinic acid in intraoperative photodynamic therapy of bladder cancer (results of multicenter trial).
Topics: Adult; Aged; Aminolevulinic Acid; Combined Modality Therapy; Cystectomy; Female; Humans; Male; Middl | 2016 |
Effect of Methyl Aminolevulinate Photodynamic Therapy With and Without Ablative Fractional Laser Treatment in Patients With Microinvasive Squamous Cell Carcinoma: A Randomized Clinical Trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Squamous Cell; Female; Humans; Lasers, Soli | 2017 |
Photodynamic diagnosis of non-muscle invasive bladder cancer using hexaminolevulinic acid.
Topics: Aminolevulinic Acid; Cystoscopy; Female; Humans; Kaplan-Meier Estimate; Light; Male; Middle Aged; Mu | 2011 |
Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy.
Topics: Aged; Aminolevulinic Acid; Canada; Carbon Radioisotopes; Cystoscopy; Diagnosis, Differential; Europe | 2012 |
48 other studies available for aminolevulinic acid and Invasiveness, Neoplasm
| Article | Year |
|---|---|
[Ⅰ. Diagnosis and Therapy for Non-Muscle Invasive Bladder Cancer Using Photodynamic Technique].
Topics: Aminolevulinic Acid; Humans; Neoplasm Invasiveness; Photochemotherapy; Photosensitizing Agents; Urin | 2022 |
Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT.
Topics: Aminolevulinic Acid; Cystoscopy; Humans; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Photoche | 2022 |
Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer.
Topics: Aminolevulinic Acid; Cystectomy; Humans; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Non-Musc | 2023 |
Photodynamic therapy for cutaneous squamous cell carcinoma in situ: Impact of anatomic location, tumor diameter, and incubation time on effectiveness.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Analysis of Variance; Biopsy, Needle; Carcinoma in Sit | 2020 |
Macro and microeconomics of blue light cystoscopy with CYSVIEW® in non-muscle invasive bladder cancer.
Topics: Aminolevulinic Acid; Cystoscopy; Humans; Neoplasm Invasiveness; Population Surveillance; Urinary Bla | 2022 |
[Initial Experience of Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumor (PDD-TURBT)].
Topics: Aged; Aminolevulinic Acid; Cystectomy; Cystoscopy; Humans; Neoplasm Invasiveness; Neoplasm Recurrenc | 2021 |
Observational Studies Requested by European Health Authorities: Governmental Interference or an Enhancement of Everyday Urological Practice? The Hexvix® Observational Patients Evaluation Study as an Example of What to Expect.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Cystectomy; Cystoscopy; Disease Progression; Di | 2017 |
'Real-life experience': recurrence rate at 3 years with Hexvix
Topics: Administration, Intravesical; Aged; Aminolevulinic Acid; Cystectomy; Cystoscopy; Female; Humans; Kap | 2017 |
Intraoperative 5-aminolevulinic acid-induced photodynamic diagnosis of metastatic brain tumors with histopathological analysis.
Topics: Adult; Aged; Aminolevulinic Acid; Brain; Brain Neoplasms; Female; Fluorescence; Humans; Intraoperati | 2017 |
Scanning Fiber Endoscope Improves Detection of 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence at the Boundary of Infiltrative Glioma.
Topics: Administration, Oral; Aminolevulinic Acid; Animals; Biotransformation; Brain Neoplasms; Cell Line, T | 2018 |
Efficacy and tolerance of photodynamic therapy for vulvar Paget's disease: a multicentric retrospective study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Neopla | 2018 |
Successful Treatment for Extensive Bowen's Disease using Daylight-mediated Photodynamic Therapy.
Topics: Aged, 80 and over; Aminolevulinic Acid; Biopsy, Needle; Bowen's Disease; Follow-Up Studies; Humans; | 2019 |
The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy.
Topics: Administration, Intravesical; Aged; Aminolevulinic Acid; Antineoplastic Agents; Cystectomy; Female; | 2020 |
Subependymal spread of recurrent glioblastoma detected with the intraoperative use of 5-aminolevulinic acid: case report.
Topics: Aminolevulinic Acid; Diagnosis, Differential; Glioblastoma; Glioma, Subependymal; Humans; Intraopera | 2013 |
[Bladder tumor targeting by Hexvix(®) fluorescence: 4 years results after prospective monocentric evaluation].
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Cystoscopy; Female; Fluorescence; France; Human | 2013 |
Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate.
Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Combined Modality Therapy; Female; Humans; Lasers, Gas; | 2013 |
Photodynamic diagnosis using 5-aminolevulinic acid during gastrectomy for gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Feasibility Studies; Female; Fluorescence; Gast | 2014 |
Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Brain Neoplasms; Cohort Studies; Disease-Free S | 2014 |
Cellular intrinsic factors involved in the resistance of squamous cell carcinoma to photodynamic therapy.
Topics: Aged, 80 and over; Aminolevulinic Acid; Animals; Biopsy; Cell Line, Tumor; Comparative Genomic Hybri | 2014 |
[Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France].
Topics: Administration, Intravesical; Aged; Aminolevulinic Acid; Carcinoma, Transitional Cell; Cost Savings; | 2015 |
Increased Histone Deacetylase Activity Involved in the Suppressed Invasion of Cancer Cells Survived from ALA-Mediated Photodynamic Treatment.
Topics: Acetylation; Aminolevulinic Acid; Azacitidine; Cell Line, Tumor; Cell Movement; Chromatin Immunoprec | 2015 |
Two-fold illumination in topical 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC): A retrospective case series and cohort study.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Cohort Studies; Confiden | 2016 |
Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma in Situ; Carcinoma, Transitional Cell; Cysto | 2017 |
Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors.
Topics: Amidines; Aminolevulinic Acid; Animals; Apoptosis; Apoptosis Regulatory Proteins; Benzoates; Benzyla | 2017 |
Motexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids.
Topics: Aminolevulinic Acid; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Dose-Response Relations | 2009 |
ALA-PDT results in phenotypic changes and decreased cellular invasion in surviving cancer cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Down-Regulat | 2009 |
Noninvasive transitional cell carcinoma is associated with a high occurrence of false positives in photodynamic diagnosis.
Topics: Aminolevulinic Acid; Carcinoma, Transitional Cell; Cystoscopy; False Positive Reactions; Female; Flu | 2009 |
Photodynamic therapy with hexenyl ester of 5-aminolevulinic acid induces necrotic cell death in salivary gland adenocarcinoma cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; C | 2010 |
Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas.
Topics: Adult; Aged; Aminolevulinic Acid; Female; Fluorescence; Humans; Male; Meningeal Neoplasms; Meningiom | 2010 |
Clearance of a thick invasive squamous cell carcinoma after multiple treatments with topical photodynamic therapy.
Topics: Administration, Topical; Aminolevulinic Acid; Biopsy, Needle; Carcinoma, Squamous Cell; Female; Foll | 2010 |
Comment concerning: Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas, Acta Neurochir DOl 1O.1007/s00701-010-0708-4, Intratumoral heterogeneity and fluorescence intensity in meningioma after 5-ALA pretreatment.
Topics: Aminolevulinic Acid; Chromosome Aberrations; Fluorescence; Genetic Heterogeneity; Humans; Intraopera | 2011 |
Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
Topics: Administration, Intravesical; Administration, Oral; Adult; Aged; Aged, 80 and over; Aminolevulinic A | 2012 |
Staging laparoscopy using ALA-mediated photodynamic diagnosis improves the detection of peritoneal metastases in advanced gastric cancer.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Animals; Disease Models, Animal; Female; Fluorescence; | 2012 |
[Photodynamic diagnosis of vulvar precancerous conditions and invasive cancers using 5-aminolevulinic acid].
Topics: Aminolevulinic Acid; Carcinoma in Situ; Diagnostic Techniques, Obstetrical and Gynecological; Female | 2003 |
5-Aminolevulinic acid-induced fluorescence in bronchial tumours: dependency on the patterns of tumour invasion.
Topics: Aminolevulinic Acid; Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Fluoresc | 2004 |
Photodynamic therapy of virus-associated epithelial tumours of the face in organ transplant recipients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Neoplasms; Humans; Keratosis | 2004 |
[Early diagnosis of laryngeal cancer].
Topics: Aminolevulinic Acid; Diagnosis, Differential; Early Diagnosis; Fluorescence; Humans; Laryngeal Neopl | 2004 |
Possibility of using laser spectroscopy for the intraoperative detection of nonfluorescing brain tumors and the boundaries of brain tumor infiltrates. Technical note.
Topics: Adult; Aminolevulinic Acid; Astrocytoma; Brain; Brain Neoplasms; Female; Humans; Lasers; Male; Middl | 2006 |
Differential effects of photofrin, 5-aminolevulinic acid and calphostin C on glioma cells.
Topics: Aminolevulinic Acid; Cell Adhesion; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; D | 2006 |
Photodynamic therapy suppresses the migration and invasion of head and neck cancer cells in vitro.
Topics: Aminolevulinic Acid; Cell Line, Tumor; Cell Movement; Cell Survival; Collagen; Drug Combinations; Ex | 2007 |
Effects of ALA-mediated photodynamic therapy on the invasiveness of human glioma cells.
Topics: Aminolevulinic Acid; Brain Neoplasms; Cell Physiological Phenomena; Dose-Response Relationship, Drug | 2006 |
Quantitative spectroscopic analysis of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence intensity in diffusely infiltrating astrocytomas.
Topics: Aged; Aminolevulinic Acid; Astrocytoma; Brain Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm | 2007 |
Use of 5-aminolevulinic acid in fluorescence-guided resection of meningioma with high risk of recurrence. Case report.
Topics: Aged; Aminolevulinic Acid; Craniotomy; Female; Fluorescence; Humans; Magnetic Resonance Imaging; Men | 2007 |
[Interdisciplinary networking for clinical and molecular questions in non-muscle invasive urothelial carcinoma of the bladder].
Topics: Aminolevulinic Acid; Biomarkers, Tumor; Carcinoma, Transitional Cell; Cooperative Behavior; Cystosco | 2007 |
Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: a clinical and histologic study.
Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Carcinoma in Situ; Carcinoma, Basal Cell; Carc | 1995 |
[The clinical value of fluorescence cystoscopy in the detection of superficial transitional epithelial cell carcinoma of the bladder].
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma in Situ; Carci | 1997 |
Photodynamic diagnosis of visceral pleural invasion of lung cancer with a combination of 5-aminolevulinic acid and autofluorescence observation systems.
Topics: Aminolevulinic Acid; Female; Humans; Levulinic Acids; Lung Neoplasms; Male; Neoplasm Invasiveness; O | 2017 |
5-Aminolevulinic acid-based photodynamic therapy of chordoma: In vitro experiments on a human tumor cell line.
Topics: Aminolevulinic Acid; Cell Line, Tumor; Chordoma; Dose-Response Relationship, Drug; Humans; Levulinic | 2017 |